Leveraging Technology to Develop New Trial Endpoints

December 17, 2018 Bill Byrom

Originally published in Applied Clinical Trials - December 2018. Click on the article image below to read.

This article reviews the "future endpoints" session chaired by Bill Byrom at this year's DIA Annual Meeting.  Bill reviews the use of wearable sensors to measure EEG activity to derive objective measures of pain; published work by researchers at Roche exploring the use of new endpoints based on remotely administered performance tests conducted using smartphones in MS patients; and work using consumer depth cameras such as Microsoft Kinect to develop new objective measures of movement.

About the Author

Bill Byrom

Bill Byrom has worked in the Pharmaceutical Industry for 28 years. Combining practical experience of roles within clinical development with a keen interest in leveraging technology, Bill is a key strategic thinker helping to shape the direction and application of eClinical solutions. Bill is a thought leader in patient-facing technologies including electronic patient-reported outcome solutions, the use of wearables and connected devices, and new novel technology-derived endpoints.

Follow on Linkedin More Content by Bill Byrom
Previous Guide
Signant Health Partner Program
Signant Health Partner Program

Become a CRO partner today. Sponsors what to know what your competitive edge is, so let's show them. We'll ...

Next Article
Game Technology Opens New Path to Clinical Endpoints - DIA Podcast
Game Technology Opens New Path to Clinical Endpoints - DIA Podcast

Dr. Bill Byrom, VP of Product Strategy & Innovation at CRF Health discusses the future of electronic patien...